Georgina Bermann

850 total citations
16 papers, 632 citations indexed

About

Georgina Bermann is a scholar working on Immunology, Cardiology and Cardiovascular Medicine and Surgery. According to data from OpenAlex, Georgina Bermann has authored 16 papers receiving a total of 632 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Immunology, 5 papers in Cardiology and Cardiovascular Medicine and 3 papers in Surgery. Recurrent topics in Georgina Bermann's work include Complement system in diseases (6 papers), Heart Failure Treatment and Management (3 papers) and Blood groups and transfusion (3 papers). Georgina Bermann is often cited by papers focused on Complement system in diseases (6 papers), Heart Failure Treatment and Management (3 papers) and Blood groups and transfusion (3 papers). Georgina Bermann collaborates with scholars based in Switzerland, United States and Sweden. Georgina Bermann's co-authors include Weinong Guo, Angelo J. Trapani, Martin Lefkowitz, David A. Calhoun, Henry Krum, William B. White, Joël Ménard, E. B. Mathiesen, Raija Tyni‐Lenné and Eva Jansson and has published in prestigious journals such as Circulation, Blood and Journal of the American College of Cardiology.

In The Last Decade

Georgina Bermann

16 papers receiving 601 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Georgina Bermann Switzerland	9	323	169	145	77	58	16	632
Maria Virginia Manzi Italy	16	412 1.3×	168 1.0×	106 0.7×	35 0.5×	79 1.4×	62	789
Hans Hillege Netherlands	11	522 1.6×	168 1.0×	104 0.7×	72 0.9×	21 0.4×	16	746
Karl Andersen Iceland	16	729 2.3×	275 1.6×	196 1.4×	100 1.3×	32 0.6×	79	1.0k
H Baglivo Argentina	12	375 1.2×	74 0.4×	99 0.7×	42 0.5×	37 0.6×	26	535
Chang‐Sheng Sheng China	18	644 2.0×	175 1.0×	177 1.2×	41 0.5×	77 1.3×	76	970
Morten Grundtvig Norway	17	436 1.3×	98 0.6×	130 0.9×	32 0.4×	41 0.7×	30	651
Myung‐A Kim South Korea	18	880 2.7×	115 0.7×	201 1.4×	42 0.5×	60 1.0×	133	1.1k
Paul Nguyen Canada	13	732 2.3×	90 0.5×	260 1.8×	45 0.6×	129 2.2×	33	1.1k
Mir Abolfazl Ostad Germany	20	484 1.5×	73 0.4×	221 1.5×	41 0.5×	147 2.5×	47	967
Guido Garavelli Italy	14	357 1.1×	165 1.0×	93 0.6×	25 0.3×	35 0.6×	23	640

Countries citing papers authored by Georgina Bermann

Since Specialization

Citations

This map shows the geographic impact of Georgina Bermann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Georgina Bermann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Georgina Bermann more than expected).

Fields of papers citing papers by Georgina Bermann

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Georgina Bermann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Georgina Bermann. The network helps show where Georgina Bermann may publish in the future.

Co-authorship network of co-authors of Georgina Bermann

This figure shows the co-authorship network connecting the top 25 collaborators of Georgina Bermann. A scholar is included among the top collaborators of Georgina Bermann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Georgina Bermann. Georgina Bermann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Risitano, Antonio M., Austin Kulasekararaj, Jaroslaw P. Maciejewski, et al.. (2025). Patient-reported improvements in paroxysmal nocturnal hemoglobinuria treated with iptacopan from 2 phase 3 studies. Blood Advances. 9(8). 1816–1826. 2 indexed citations

Bermann, Georgina, S. Vallow, & David Cella. (2023). PCR248 Meaningful Within-Patient Change Threshold Range for the FACIT-Fatigue in Paroxysmal Nocturnal Hemoglobinuria (PNH). Value in Health. 26(12). S497–S497. 1 indexed citations

Castro, Carlos de, Phillip Scheinberg, Susan Vallow, et al.. (2023). Patient Experience Interviews with a Novel Treatment Iptacopan for Paroxysmal Nocturnal Hemoglobinuria. Blood. 142(Supplement 1). 7339–7339. 4 indexed citations

Risitano, Antonio M., Carlos M. de Castro, Bing Han, et al.. (2023). Patient-Reported Improvements in Fatigue and Health-Related Quality of Life in the Phase 3 Studies Apply-PNH and Appoint-PNH Evaluating the Use of Iptacopan in C5 Inhibitor-Treated and Treatment-Naïve Patients with Paroxysmal Nocturnal Hemoglobinuria. Blood. 142(Supplement 1). 487–487. 2 indexed citations

Latour, Régis Peffault de, Bing Han, Yasutaka Ueda, et al.. (2021). CT-121: Phase 3 Study of the Efficacy and Safety of Iptacopan (LNP023), an Oral Factor B Inhibitor, in Adult Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH) Naïve to Complement Inhibitor Therapy. Clinical Lymphoma Myeloma & Leukemia. 21. S450–S450. 4 indexed citations

Risitano, Antonio M., Austin Kulasekararaj, Carlos M. de Castro, et al.. (2021). CT-118: PH3 Study of Efficacy and Safety of Iptacopan (LNP023), an Oral Complement Factor B Inhibitor, in Patients with Paroxysmal Nocturnal Hemoglobinuria and Residual Anemia Despite Anti-C5 Antibody Treatment. Clinical Lymphoma Myeloma & Leukemia. 21. S449–S450. 2 indexed citations

Filippatos, Gerasimos, Sadiya S. Khan, Andrew P. Ambrosy, et al.. (2015). International REgistry to Assess Medical Practice with lOngitudinal obseRvation for Treatment of Heart Failure (REPORT-HF): Rationale for and Design of a Global Registry. European Journal of Heart Failure. 17(5). 527–533. 46 indexed citations

Holzhauer, Björn, Mouna Akacha, & Georgina Bermann. (2015). Choice of estimand and analysis methods in diabetes trials with rescue medication. Pharmaceutical Statistics. 14(6). 433–447. 21 indexed citations

Calhoun, David A., William B. White, Henry Krum, et al.. (2011). Effects of a Novel Aldosterone Synthase Inhibitor for Treatment of Primary Hypertension. Circulation. 124(18). 1945–1955. 159 indexed citations

10.

Singer, Jonathan B., Hallvard Holdaas, Alan G. Jardine, et al.. (2007). Genetic analysis of fluvastatin response and dyslipidemia in renal transplant recipients. Journal of Lipid Research. 48(9). 2072–2078. 20 indexed citations

11.

Gullestad, Lars, John Wikstrand, Prakash Deedwania, et al.. (2005). What resting heart rate should one aim for when treating patients with heart failure with a beta-blocker?. Journal of the American College of Cardiology. 45(2). 252–259. 89 indexed citations

12.

Malik, Rayaz A., et al.. (2005). Effects of Angiotensin Type-1 Receptor Antagonism on Small Artery Function in Patients With Type 2 Diabetes Mellitus. Hypertension. 45(2). 264–269. 40 indexed citations

13.

Tyni‐Lenné, Raija, Allan Gordon, Eva Jansson, Georgina Bermann, & Christer Sylvén. (1997). Skeletal muscle endurance training improves peripheral oxidative capacity, exercise tolerance, and health-related quality of life in women with chronic congestive heart failure secondary to either ischemic cardiomyopathy or idiopathic dilated cardiomyopathy. The American Journal of Cardiology. 80(8). 1025–1029. 97 indexed citations

14.

Rylander, Emma, Göran Pershagen, Margareta Eriksson, & Georgina Bermann. (1995). PARENTAL SMOKING, URINARY COTININE, AND WHEEZING BRONCHITIS IN CHILDREN. Epidemiology. 6(3). 289–293. 62 indexed citations

15.

Mathiesen, E. B., et al.. (1995). Total hip replacement and cancer. A cohort study. Journal of Bone and Joint Surgery - British Volume. 77-B(3). 345–350. 76 indexed citations

16.

Bermann, Georgina. (1993). Estimation and inference in bivariate and multivariate ordinal probit models. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact